Abinash Parida
-
EzeRx registers 167 per cent growth in year-on-year net revenue
The company attributed its profits to the popularity of its flagship product, EzeCheck EzeRx, a leading innovator in non-invasive diagnostic…
Read More »
The company attributed its profits to the popularity of its flagship product, EzeCheck EzeRx, a leading innovator in non-invasive diagnostic…
Read More »